Centogene N.V. (CNTGF)
OTCMKTS · Delayed Price · Currency is USD
0.1050
0.00 (0.00%)
Dec 2, 2025, 4:00 PM EST
Centogene Market Cap
Centogene has a market cap or net worth of $3.13 million as of December 3, 2025. Its market cap has decreased by -70.98% in one year.
Market Cap
3.13M
Enterprise Value
n/a
Revenue
53.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since November 5, 2019, Centogene's market cap has decreased from 3.22M to 3.13M, a decrease of -2.77%. That is a compound annual growth rate of -0.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 3.13M | -20.39% |
| Dec 31, 2024 | 3.93M | -88.24% |
| Dec 29, 2023 | 33.44M | 32.77% |
| Dec 30, 2022 | 25.19M | -78.60% |
| Dec 31, 2021 | 117.70M | -50.06% |
| Dec 31, 2020 | 235.67M | 17.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Elite Pharmaceuticals | 571.69M |
| Glass House Brands | 486.41M |
| American Oncology Network | 429.20M |
| CytoDyn | 414.34M |
| Northwest Biotherapeutics | 394.75M |
| Silence Therapeutics | 318.36M |
| Nika Pharmaceuticals | 259.91M |